AAAAAA
Results:
1-7
|
Results: 7
Authors:
Remberger, M
Aschan, J
Lonnqvist, B
Carlens, S
Gustafsson, B
Hentschke, P
Klaesson, S
Mattsson, J
Ljungman, P
Ringden, O
Citation: M. Remberger et al., An ethnic role for chronic, but not acute, graft-versus-host disease afterHLA-identical sibling stem cell transplantation, EUR J HAEMA, 66(1), 2001, pp. 50-56
Authors:
Remberger, M
Aschan, J
Lonnqvist, B
Carlens, S
Gustafsson, B
Hentschke, P
Klaesson, S
Mattsson, J
Ljungman, P
Ringden, O
Citation: M. Remberger et al., An ethnic role for chronic, but not acute, graft-versus-host disease afterHLA-identical sibling stem cell transplantation, TRANSPLAN P, 33(1-2), 2001, pp. 1769-1770
Authors:
Ringden, O
Remberger, M
Lehmann, S
Hentschke, P
Mattsson, J
Klaesson, S
Aschan, J
Citation: O. Ringden et al., N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation, BONE MAR TR, 25(9), 2000, pp. 993-996
Authors:
Bjork, IN
Brissac, C
Remberger, M
Mattsson, J
Klaesson, S
Ringden, O
Stewart, J
Lundkvist, I
Citation: In. Bjork et al., Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT), CLIN EXP IM, 119(1), 2000, pp. 240-249
Authors:
Klaesson, S
Citation: S. Klaesson, Clinical use of rHuEPO in bone marrow transplantation, MED ONCOL, 16(1), 1999, pp. 2-7
Authors:
Aschan, J
Carlens, S
Hagglund, H
Klaesson, S
Mattsson, J
Remberger, M
Citation: J. Aschan et al., Improved survival after bone marrow transplantation for early leukemia using busulfan-cyclophosphamide and individualized prophylaxis against graft-versus-host disease: a long-term follow-up, CLIN TRANSP, 13(6), 1999, pp. 512-519
Authors:
Hagglund, H
Remberger, M
Klaesson, S
Lonnqvist, B
Ljungman, P
Ringden, O
Citation: H. Hagglund et al., Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation, BLOOD, 92(12), 1998, pp. 4568-4572
Risultati:
1-7
|